CD8A and neoplasm: They proved that Met@Man-MPs could degrade tumor collagen to support the infiltration of CD8 + T cells into tumor interiors and enhance tumor penetration of ICI, boosting immune checkpoint inhibition therapy and improving anticancer efficacy and long-term memory immunity after combinational treatment [104].